The estimated Net Worth of R Carter Pate is at least $2.19 Milion dollars as of 3 September 2024. Mr. Pate owns over 1,465 units of Option Care Health stock worth over $1,171,566 and over the last 10 years he sold OPCH stock worth over $556,663. In addition, he makes $461,672 as Independent Director at Option Care Health.
Sign up
Mr. Pate OPCH stock SEC Form 4 insiders trading
R has made over 15 trades of the Option Care Health stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 1,465 units of OPCH stock worth $47,422 on 3 September 2024.
The largest trade he's ever made was buying 30,000 units of Option Care Health stock on 27 May 2021 worth over $16,500. On average, R trades about 2,402 units every 59 days since 2015. As of 3 September 2024 he still owns at least 36,126 units of Option Care Health stock.
You can see the complete history of Mr. Pate stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
R. Carter Pate biography
R. Carter Pate serves as Independent Director of the Company. Mr. Pate is currently the Founder and Chief Executive Officer of Phoenix Effect, LLC, serving as a Consultant and Advisory Board Member to public and private Boards of Directors since 2014. Mr. Pate also currently serves as Interim Chief Executive Officer of Providence Service Corporation and as a director, since 2016, of Advanced Emissions Solutions, Inc., a publicly traded emissions solutions provider. Mr. Pate has been nominated to become a director of Red Lion Hotels in April 2019. Mr. Pate previously served as Chief Executive Officer of MV Transportation, Inc., the largest privately-owned passenger transportation contracting firm based in the U.S. from 2011 to 2014. From 1996 to 2011, Mr. Pate was employed by PricewaterhouseCoopers, LLP (“PwC”), the world’s largest accounting and professional services firm. From 2010 to 2011, he was the U.S. and Global Managing Partner of PwC’s Capital Projects and Infrastructure practice. From 2008 to 2010, he was the Global and U.S. Managing Partner of PwC’s Health Care Practice, and from 2005 to 2008, he was the U.S. Managing Partner of Government Services. From 2004 to 2005, Mr. Pate was PwC’s Managing Partner of U.S. Markets, and from 2000 to 2004, Mr. Pate was PwC’s Managing Partner of Financial Advisory Services. He served as a Partner and Leader in PwC’s U.S. Restructuring Practices from 1996 to 2000. Mr. Pate previously served as a director, Interim President and Chief Executive Officer of Sun Television and Appliances, Inc., a national retailer, as a director and Chief Executive Officer of Sun Coast Industries, Inc. and as Director of Finance at William Hudson Chemical Trading. Mr. Pate has a Master’s degree in Accounting and Information Management from the University of Texas at Dallas and a B.S. degree in Accounting from Greensboro College and is a CPA.
What is the salary of R Pate?
As the Independent Director of Option Care Health, the total compensation of R Pate at Option Care Health is $461,672. There are 7 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.
How old is R Pate?
R Pate is 65, he's been the Independent Director of Option Care Health since 2019. There are 1 older and 20 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.
What's R Pate's mailing address?
R's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.
Insiders trading at Option Care Health
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten oraz Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
What does Option Care Health do?
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
What does Option Care Health's logo look like?
Complete history of Mr. Pate stock trades at Advanced Emissions Solutions Inc, Teligent Inc, Providence Service Corp, Red Lion Hotels, Purple Innovation Inc oraz Option Care Health
Option Care Health executives and stock owners
Option Care Health executives and other stock owners filed with the SEC include:
-
Harriet Booker,
Chief Operating Officer -
Harriet Booker,
Chief Operating Officer -
Rich Denness,
Chief Strategy Officer -
John Rademacher,
Chief Executive Officer, Director -
John C. Rademacher,
CEO, Pres & Director -
Michael Shapiro,
Chief Financial Officer -
Michael H. Shapiro,
CFO & Sr. VP -
R. Carter Pate,
Independent Director -
Clifford Berman,
General Counsel -
Richard P. Denness,
Chief Commercial Officer -
Clifford E. Berman,
Sr. VP, Gen. Counsel & Corp. Sec. -
Harry Jansen Kraemer,
Independent Non-Executive Chairman of the Board -
David Golding,
Independent Director -
John Arlotta,
Independent Director -
Nitin Sahney,
Independent Director -
Timothy Sullivan,
Director -
Elizabeth Betten,
Director -
Mark Vainisi,
Director -
Alan Nielsen,
Director -
Christopher Hartman,
Chief Growth Officer -
Luke Whitworth,
Sr. VP of Revenue Cycle Management -
Julie Koenig,
Sr. VP of Operations -
Christopher Frederick Hartman,
Chief Growth Officer -
Matthew Deans,
Sr. VP of Bus. Devel. -
Michael W. Rude,
Sr. VP & Chief HR Officer -
Cari Reed,
Sr. VP & Chief Compliance Officer -
Brett Michalak,
Chief Information Officer -
Robert R. Kampstra,
Sr. VP of Fin. & Chief Accounting Officer -
Femi Adewunmi,
Chief Medical Officer -
Barbara W. Bodem,
Director -
Norman L. Wright,
Director -
Boots Alliance, Inc.Och Us ...,
-
Dearborn Partners Llcmadiso...,
-
Dearborn Capital Partners V...,
-
Elizabeth D Bierbower,
Director -
Collin Smyser,
GC & Corporate Secretary -
Natasha Deckmann,
Director -
Seema Kumbhat,
Chief Medical Officer -
Dearborn Partners Llcmadiso...,
-
Robert R Kampstra,
CHIEF ACCOUNTING OFFICER -
Dearborn Partners Llcmadiso...,
-
Luke Whitworth,
Chief Operating Officer -
Michael Bavaro,
Chief Human Resources Officer -
Christopher L. Grashoff,
Chief Growth Officer -
Eric Brandt,
Director